Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Z Zang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Zhonghua Yi Xue Za Zhi|April 8, 2019
[Clinical efficacy of different vascular reconstruction on adult moyamoya disease]S J Pan, Y Zhang, Y Hou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis]J Shi, Z M Zhu, K Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Statistical parametric mapping analysis of J S Chu, T H Liu, Y Z Zang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Efficacy of combination of ATRA, ATO and anthracyclines induction therapy in patients with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Zhonghua Yi Xue Za Zhi|April 8, 2019
[Clinical efficacy of different vascular reconstruction on adult moyamoya disease]S J Pan, Y Zhang, Y Hou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis]J Shi, Z M Zhu, K Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Statistical parametric mapping analysis of J S Chu, T H Liu, Y Z Zang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Efficacy of combination of ATRA, ATO and anthracyclines induction therapy in patients with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Pageof 2